Fund Name | : | ITI Mutual Fund |
Scheme Name | : | ITI Pharma and Healthcare Fund (G) |
AMC | : | ITI Mutual Fund |
Type | : | O |
Category | : | Equity - Pharma |
Launch Date | : | 18-Oct-2021 |
Fund Manager | : | Rohan Korde |
Net Assets (Rs. cr) | : | 160.39 |
Invest wise with Expert advice
Get better recommendations Make better investments.
Get better recommendations Make better investments.
By continuing, I accept the Terms & Conditions and agree to receive communication on Whatsapp
NAV Date | : | 16-Apr-2024 |
NAV [Rs.] | : | 13.55 |
Buy/Resale Price [Rs.] | : | 0 |
Sell/Repurchase Price [Rs.] | : | 0 |
Entry Load % | : | Nil |
Exit Load % | : | 1% if redeemed or switched out on or before completion of 12 months from the date of allotment of units; Nil, if redeemed or switched out after completion of 12 months from the date of allotment of units. |
1w | 1m | 3m | 6m | 1y | 3y | 5y | Since INC | |
---|---|---|---|---|---|---|---|---|
Scheme Returns | -1.99 | 4.07 | 6.65 | 22.84 | 46.70 | 13.27 | ||
Category Avg | -1.79 | 2.95 | 6.74 | 23.49 | 52.07 | 16.58 | 23.24 | 19.24 |
Category Best | -0.57 | 6.58 | 9.58 | 26.93 | 60.01 | 19.68 | 27.27 | 37.17 |
Category Worst | -1.99 | 4.07 | 6.65 | 22.84 | 46.70 | 13.27 |
Dividends | Bonus |
---|
No Record Found
Min. Investment(Rs.) | : | 5000 |
Increm.Investment(Rs.) | : | 1000 |
Calculate the worth of your wealth at retirement
In | |
Name of the Company | No of shares |
No Record Found
Out | |
Name of the Company | No of shares |
No Record Found
Asset Type | Instrument Name | Industry | Net Assets(%) | No of Shares | Mkt Value(Cr.) | ||||
---|---|---|---|---|---|---|---|---|---|
Equity & Equity related Investments | |||||||||
Equity | Sun Pharma.Inds. | Pharmaceuticals & Biotechnology | 16.71 | 1,65,338.00 | 26.79 | ||||
Equity | Lupin | Pharmaceuticals & Biotechnology | 6.00 | 59,516.00 | 9.62 | ||||
Equity | Max Healthcare | Healthcare Services | 5.74 | 1,12,354.00 | 9.21 | ||||
Equity | Dr Reddy's Labs | Pharmaceuticals & Biotechnology | 5.38 | 14,017.00 | 8.63 | ||||
Equity | Mankind Pharma | Pharmaceuticals & Biotechnology | 5.15 | 35,874.00 | 8.25 | ||||
Equity | Suven Pharma | Pharmaceuticals & Biotechnology | 4.56 | 1,08,019.00 | 7.31 | ||||
Equity | Apollo Hospitals | Healthcare Services | 4.47 | 11,272.00 | 7.17 | ||||
Equity | Zydus Lifesci. | Pharmaceuticals & Biotechnology | 3.86 | 61,479.00 | 6.19 | ||||
Equity | Divi's Lab. | Pharmaceuticals & Biotechnology | 3.59 | 16,724.00 | 5.76 | ||||
Equity | Cipla | Pharmaceuticals & Biotechnology | 3.28 | 35,158.00 | 5.26 | ||||
Equity | Laurus Labs | Pharmaceuticals & Biotechnology | 2.79 | 1,14,108.00 | 4.48 | ||||
Equity | Syngene Intl. | Healthcare Services | 2.39 | 54,564.00 | 3.83 | ||||
Equity | Torrent Pharma. | Pharmaceuticals & Biotechnology | 2.22 | 13,689.00 | 3.56 | ||||
Equity | Aurobindo Pharma | Pharmaceuticals & Biotechnology | 2.19 | 32,196.00 | 3.51 | ||||
Equity | Alembic Pharma | Pharmaceuticals & Biotechnology | 2.01 | 32,738.00 | 3.22 | ||||
Equity | J B Chem & Pharm | Pharmaceuticals & Biotechnology | 1.93 | 18,761.00 | 3.10 | ||||
Equity | FDC | Pharmaceuticals & Biotechnology | 1.85 | 69,869.00 | 2.97 | ||||
Equity | Orchid Pharma | Pharmaceuticals & Biotechnology | 1.73 | 26,555.00 | 2.77 | ||||
Equity | Health.Global | Healthcare Services | 1.68 | 79,670.00 | 2.69 | ||||
Equity | Piramal Pharma | Pharmaceuticals & Biotechnology | 1.67 | 2,07,285.00 | 2.67 | ||||
Equity | Archean Chemical | Chemicals & Petrochemicals | 1.58 | 37,900.00 | 2.54 | ||||
Equity | Ipca Labs. | Pharmaceuticals & Biotechnology | 1.47 | 19,066.00 | 2.36 | ||||
Equity | Vijaya Diagnost. | Healthcare Services | 1.39 | 35,064.00 | 2.23 | ||||
Equity | SPARC | Pharmaceuticals & Biotechnology | 1.35 | 58,628.00 | 2.16 | ||||
Equity | Vishnu Chemicals | Chemicals & Petrochemicals | 1.27 | 63,910.00 | 2.04 | ||||
Equity | Ajanta Pharma | Pharmaceuticals & Biotechnology | 1.27 | 9,125.00 | 2.04 | ||||
Equity | Caplin Point Lab | Pharmaceuticals & Biotechnology | 1.21 | 14,758.00 | 1.94 | ||||
Equity | Shilpa Medicare | Pharmaceuticals & Biotechnology | 1.06 | 36,802.00 | 1.69 | ||||
Equity | Rainbow Child. | Healthcare Services | 1.03 | 12,783.00 | 1.66 | ||||
Equity | Glaxosmi. Pharma | Pharmaceuticals & Biotechnology | 0.99 | 8,179.00 | 1.59 | ||||
Equity | Abbott India | Pharmaceuticals & Biotechnology | 0.99 | 585.00 | 1.59 | ||||
Equity | Sanofi India | Pharmaceuticals & Biotechnology | 0.99 | 1,952.00 | 1.58 | ||||
Equity | Jupiter Life Lin | Healthcare Services | 0.98 | 13,176.00 | 1.58 | ||||
Equity | Fortis Health. | Healthcare Services | 0.94 | 35,946.00 | 1.51 | ||||
Equity | Sequent Scien. | Pharmaceuticals & Biotechnology | 0.90 | 1,24,339.00 | 1.44 | ||||
Equity | Astec Lifescienc | Fertilizers & Agrochemicals | 0.78 | 11,754.00 | 1.25 | ||||
Equity | Strides Pharma | Pharmaceuticals & Biotechnology | 0.72 | 14,800.00 | 1.16 | ||||
Cash & Cash Equivalent | |||||||||
Net CA & Others | Net CA & Others | -/- | 1.88 | 0.00 | 3.02 |
Fund House | : ITI Asset Management Ltd |
Incorporation Date | : 10-Jan-2008 |
Total Assets Managed (Cr.) | : 6,396.16 |
Trustee/s | : |
Chairman | : N/A |
CEO / MD | : Mr. Hitesh Thakkar |
CIO | : N/A |
President | : N/A |
Director/s | : Mr.Rakesh P khanna |
Compliance Officer/s | : Mr. C. Balasubramanian |
Investor Service Officer/s | : N/A |
Fund Manager/s | : Rohan Korde |
Auditors | : N/A |
Registered Office | : ITI House 36, Dr.R.K.Shirodkar Marg, Parel Mumbai - 400012,400013 |
Contact Nos | : 022-66214999 |
Fax | : 022-66214998 |
: mfassist@itiorg.com | |
Website | : www.itimf.com |
www.indiainfoline.com is part of the IIFL Group, a leading financial services player and a diversified NBFC. The site provides comprehensive and real time information on Indian corporates, sectors, financial markets and economy. On the site we feature industry and political leaders, entrepreneurs, and trend setters. The research, personal finance and market tutorial sections are widely followed by students, academia, corporates and investors among others.
Copyright © IIFL Securities Ltd. All rights Reserved.
Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213, IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
This certificate demonstrates that IIFL as an organization has defined and put in place best-practice information security processes.
www.indiainfoline.com is part of the IIFL Group, a leading financial services player and a diversified NBFC. The site provides comprehensive and real time information on Indian corporates, sectors, financial markets and economy. On the site we feature industry and political leaders, entrepreneurs, and trend setters. The research, personal finance and market tutorial sections are widely followed by students, academia, corporates and investors among others.
Copyright © IIFL Securities Ltd. All rights Reserved.
Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213, IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
This certificate demonstrates that IIFL as an organization has defined and put in place best-practice information security processes.